POINT Biopharma Global Inc. (PNT) Reports Q3 Loss of $0.86/sh

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q3 EPS of ($0.86), versus ($0.75) reported last year. Revenue for the quarter came in at $869.7 thousand, versus $159.5 thousand reported last year.

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• Barclays sees reasons to take risk off the table in September
• Snowflake soars 20% on earnings beat and raised guidance
• Citi raises Broadcom price target to $515 amid AI outlook